In the fast-paced and highly competitive world of pharmaceuticals, retaining top talent is no small feat. Ferring Pharmaceuticals, a Swiss biopharmaceutical company, has found a winning strategy by focusing on holistic worker well-being and steadfastly committing to diversity, equity, and inclusion
The biopharmaceutical industry has been shaken by the European Union's recent ban on Triton X-100, a detergent essential for preventing viral contamination in biologics and plasma-derived products. Since its enactment in 2021, this regulatory change has catalyzed a worldwide search for
As the U.S. presidential election looms, the conversation around pharmaceutical policies intensifies, with Vice President Kamala Harris and former President Donald Trump proposing divergent paths. Harris and Trump represent fundamentally different approaches to drug pricing reforms, reflecting
The biopharmaceutical industry is undergoing a significant transformation, driven by the need for speed, safety, and cost-efficiency in therapeutic production. The advent of new modalities like cell and gene therapies has added layers of complexity to the already intricate production pipelines. As
The biotech industry is bustling with innovation and potential, and Xeris Biopharma Holdings Inc (NASDAQ: XERS) is making waves. This article aims to delve deep into the nuts and bolts of Xeris Biopharma’s recent market activities, financial health, insider trading, analysts' ratings, valuation
The biopharma sector is facing a significant wave of layoffs in 2024, affecting thousands of employees across various companies. This trend is shaped by numerous internal and external factors, including corporate restructuring, market adaptations, strategic divestments, and cost-saving measures.
